Highlights Annual revenues may drop for the first time since its listing The company is facing supply chain constraints for a year now with the issues yet to be resolved fully Competitive intensity increased in the US market and new products' scale-up is lagging expectations Growth rates may languish in the near term. New initiatives still in scale-up stage Gland Pharma’s revenue dropped for the third consecutive quarter in the December 2022 quarter, sending its shares to a new 52-week low on Tuesday. Revenue...
Moneycontrol Pro Panorama | Equity traders get the rough end of the stick
Jan 27, 2023 / 04:57 PM IST
In today’s edition of Moneycontrol Pro Panorama: Should investors worry about turnover ratio, can banks pull up Nifty, problems ...Read Now
To read the full story, Subscribe to Moneycontrol PRO
Access the exclusive stories, weekly investment ideas and daily technical calls in an Ad free experience
Already a member? Sign in
Limited Period offer on Moneycontrol PRO. Subscribe to PRO and get up to
Ad free experience
Experience a non-intrusive navigation and faster response in the ad free mode
Access to 230+ exclusive stories per month from our editorial and Experts
Have a Global edge with access to content from world renowned experts and journalist
Access to 40+ weekly investment ideas including 4 daily technical calls
Exclusive access to live webinars from market experts on trading and investment strategies
Daily and weekly insights bundled and sent to your inbox to keep you ahead in the race.
Get upto 50% discount on limited period offers